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Presidents’ Health and Medical Confidentiality
With the recent election of Joe Biden Jr, whoiscurrently
78 years old and will be the oldest person inaugurated
as US President, potential issues related to presidential
health may emerge along with dilemmas concerning the
privacy and confidentiality of the president’s medical in-
formation. Questions arise about what information the
public has a right to know about a president’s health and
who should decide and how. These issues require atten-
tion and informed public and professional discussion.
Similar issues have surfaced in the past, but are in-
creasingly important, given rising social media and politi-
cal polarization, shifts in relevant laws and norms, more in-
dividuals working into their 70s and 80s, and specifics of
a particular situation. Over the past century, several presi-
dents have had significant disease, many details of which
were hidden from the public, including the extent of
Woodrow Wilson’s stroke and cognitive compromise,
Franklin D. Roosevelt’s paralysis, Dwight Eisenhower’s
strokewithtransientmotoraphasia,andJohnF.Kennedy’s
use of corticosteroids, narcotic analgesics, and amphet-
amines for Addison disease, back pain, and fatigue.1 Ob-
servers have suggested that Ronald Reagan, diagnosed
with Alzheimer dementia after his presidency, was devel-
oping cognitive deficits while in office. In October 2020,
Donald Trump’s hospitalization for coronavirus disease
2019 (COVID-19) raised many critical issues regarding the
privacy and confidentiality of his medical information. He
and his physician were criticized for withholding key in-
formation, including when the president first tested posi-
tive for the virus (whether it was before the first presiden-
tial debate) and whether he developed pneumonia.
Yet ethical tensions emerge. For centuries, pa-
tients have had certain rights to privacy and confiden-
tiality, enabling them to trust physicians with sensitive
information. However, in a democracy, governmental
transparency is crucial—as embodied, for instance, in the
Freedom of Information Act—to ensure and maintain
public trust. Democratic governments serve at the be-
hest of the people, who must therefore be aware of rel-
evant information concerning elected officials, in part to
hold them accountable.
Bioethics, too, emphasizes principles of not only
rights to privacy, but also beneficence, nonmalefi-
cence, and justice. Physicians thus need to minimize risks
and promote individual and social well-being and social
justice. Limits exist on patient confidentiality when se-
rious risks may ensue to others. For example, when pa-
tients have sexually transmitted infections, public health
departments engage in contact tracing. Also, in the
Tarasoff decision, based on a 1969 case, the Supreme
Court of California ruled that a psychotherapist may need
to break patients’ confidentiality if the patient ex-
presses an intention or plan to harm others.
Many individuals in the US support the release of rel-
evant medical information about presidents and presi-
dential candidates. In 2016, in a survey of 1033 people,
51% of respondents, including 66% of Republicans and
47% of Democrats, said presidents should release all
medical information.2
Accordingly, disclosure of critical information about
a president’s COVID-19 infection would be consistent with
this expectation and could potentially prevent national
concerns that a president’s health and fitness could im-
pede his or her abilities to discharge the duties and pow-
ers of the office. COVID-19 causes considerable neuro-
logical, cognitive, and psychiatric problems. In a study of
509 hospitalized patients, 82% developed neurological
symptoms.3 In another study of 292 patients with COVID-
19, 47% of the 89 patients who were older than age 50
years reported not returning to their prior state of health
at 2 to 3 weeks after acquiring the infection, and 20%, re-
gardless of age, still reported confusion at 2 to 3 weeks.4
Thus, disclosure of critical health information is im-
portant, but must be balanced against a patient’s right
to privacy and the benefits of disclosure. President
Trump’s physician insisted that the Health Insurance Por-
tability and Accountability Act (HIPAA) prevented the re-
lease of additional details about the president’s medi-
cal condition. Yet HIPAA does not apply if patients decide
to disclose their information to others, and the presi-
dent could thus potentially release more of his health in-
formation without HIPAA being a barrier.
The 25th Amendment, ratified in 1967, following
President Kennedy’s assassination, stipulates that if the
vice president and the majority of “either the principal
officers of the executive departments or of such other
body as Congress may by law provide” declares that “the
president is unable to discharge the powers and duties
of his office,” the vice president shall assume these
duties.5 Reasons to replace the president if he or she is
unable to fulfill presidential powers and duties may in-
clude death, resignation, removal, or incapacitation due
to serious physical or mental illness.
In 1994, former President Jimmy Carter and others
raised concerns about the 25th Amendment, including
that it focused solely on medical information from the
president’s personal physician, who might, however,
have a conflict of interest (COI) at least in part related
to loyalty to the president. Hence, Carter proposed cre-
ation of a nonpartisan group of medical experts.6 The
Carter Center and Bowman Gray School of Medicine es-
tablished a Working Group on Presidential Disability,
which provided recommendations to President Bill
Clinton in 1996.7 This working group concluded that the
25th Amendment did not require revision, but that
“guidelines are needed to ensure its effective implemen-
tation,” and that while “determination of presidential im-
pairment is a medical judgement…determination of
presidential inability is a political judgement.”7 The group









1051 Riverside Dr, No.




jama.com (Reprinted) JAMA January 5, 2021 Volume 325, Number 1 25
© 2020 American Medical Association. All rights reserved.
Downloaded From: https://jamanetwork.com/ by a Columbia University Libraries User  on 04/12/2021
“best source of information” about the president’s health, the presi-
dent or designees have the responsibility “to make accurate disclo-
sures to the public.”7
Over the past quarter-century since this report, however, po-
litical and legal landscapes have changed. In the past, for instance,
a norm existed by which candidates voluntarily submitted their pri-
vate tax returns and their medical information, but this norm of open-
ness has now eroded.
The group also dismissed as “unwarranted” potential criticism that
the vice president and cabinet might be “unlikely to seek to remove
the president…when they clearly should.”7 Yet, especially given cur-
rent political polarization, these officials would have significant COIs
in removing their party’s elected president and might not do so. Ar-
guably, situations could arise in which the president’s physician should,
in the name of national security, override the president’s decision to
keep certain medical information confidential. Yet the likelihood of
such a physician doing so, given the inherent COIs, is very low.
The group considered, but most of its members disagreed with,
a proposal to establish a separate committee of physicians, nomi-
nated by the Institute of Medicine, to objectively assess the medi-
cal fitness for office of presidents, vice presidents, and candidates.7
On October 9, 2020, House Speaker Nancy Pelosi proposed leg-
islation that would build on the 25th Amendment by establishing a
standing bipartisan commission that would require presidents un-
dergo physical examinations yearly, on the basis of which the commis-
sion would objectively judge the president’s fitness for office.8 Pelosi’s
bill to create such a commission, though opposed by President Trump’s
supporters, reflects Carter’s proposal and the previous deliberations
of the working group. Congress at present is not expected to enact
Speaker Pelosi’s bill, yet she has said, “This is not about President
Trump…but he shows the need for us to create a process for future
Presidents.”8 She may, therefore, propose the bill again in next year’s
Congress, and these issues will surely continue to arise over time.
Yet assessing presidents’ fitness for office poses challenges. Evalu-
ation of certain risks, especially those involving psychiatric diagno-
ses or cognitive dysfunction, can be difficult. Transparency is key, and
withholding essential information appears unwarranted. Yet, before
a commission should start assessing presidents’ fitness, careful con-
sideration is crucial regarding whether such objective criteria could
even be established, and if so, what those criteria might be. Clearer
guidelines are needed regarding how to address the complexities and
nuances of where to draw the line. Reputable professional organiza-
tions, such as the National Academy of Medicine, the American Medi-
cal Association, and the American Psychiatric Association, with input
from relevant medical experts, should consider developing and ar-
ticulating standards, clarifying many of these issues.
Such guidelines should differentiate among various types of
medical information. Determinations need to be made regarding
whether particular types of information are indeed relevant to abili-
ties to perform the duties of the office. Diagnoses of cancer, for in-
stance, which several presidential candidates (eg, Bob Dole) have
reported, may require periodic hospitalization and even may be fa-
tal, shortening presidents’ terms, but might not necessarily ham-
per their cognitive capabilities to perform their duties. Psychiatric
symptoms, however, could potentially interfere with presidents’
judgment. Yet, a history of psychiatric treatment does not impair
presidents’ abilities. Still, assessments of the potential effects of cur-
rent psychiatric symptoms on these abilities can be difficult. Estab-
lished guidelines for determining patients’ capacities, such as for mak-
ing a particular decision regarding their medical care, do not readily
apply to presidents, who make countless decisions daily.
Careful consideration of whether such guidelines are possible,
and if so, how, is clearly worth pursuing, along with education of poli-
cymakers, the public, and others regarding the complexities in-
volved. Such guidelines would pose problems if they dissuaded presi-
dents from seeking necessary medical treatment. But such physical
examinations and release of relevant information, if required, could
become expected norms, along with other requirements of the of-
fice. Individuals who do not wish to follow these could choose not
to seek the position. These needs for transparency could poten-
tially extend to other government officials, but presumably would
be important only if these individuals pose significant potential harms
to the safety and security of significant numbers of people.
As life expectancy increases and as many presidents and some
presidential candidates enter the eighth or ninth decade of their
lives, these challenges will be increasingly important. Careful dis-
cussion of issues related to presidential health and confidentiality
of the president’s health information, as well as careful assessment
of the complexities involved by appropriate professional organiza-
tions, is crucial and timely.
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